A detailed history of Montag A & Associates Inc transactions in Natera, Inc. stock. As of the latest transaction made, Montag A & Associates Inc holds 174 shares of NTRA stock, worth $29,103. This represents 0.0% of its overall portfolio holdings.

Number of Shares
174
Previous 18 866.67%
Holding current value
$29,103
Previous $1,000 2100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$97.75 - $129.67 $15,249 - $20,228
156 Added 866.67%
174 $22,000
Q2 2024

Jul 31, 2024

BUY
$85.28 - $112.6 $85 - $112
1 Added 5.88%
18 $1,000
Q1 2024

May 07, 2024

BUY
$59.21 - $92.9 $59 - $92
1 Added 6.25%
17 $1,000
Q3 2023

Nov 09, 2023

BUY
$43.4 - $62.52 $86 - $125
2 Added 14.29%
16 $0
Q2 2023

Aug 09, 2023

SELL
$47.08 - $55.16 $47 - $55
-1 Reduced 6.67%
14 $0
Q4 2022

Feb 02, 2023

SELL
$34.17 - $47.91 $6,355 - $8,911
-186 Reduced 92.54%
15 $0
Q3 2022

Nov 09, 2022

BUY
$36.93 - $56.68 $7,422 - $11,392
201 New
201 $9,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.